508 related articles for article (PubMed ID: 24290834)
1. [Ocular manifestations in Behçet's disease].
Zeghidi H; Saadoun D; Bodaghi B
Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
[TBL] [Abstract][Full Text] [Related]
2. [Ocular manifestations of Behçet's disease].
Cassoux N; Fardeau C; Lehoang P
Ann Med Interne (Paris); 1999 Nov; 150(7):529-34. PubMed ID: 10637668
[TBL] [Abstract][Full Text] [Related]
3. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
Amer R; Alsughayyar W; Almeida D
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
[TBL] [Abstract][Full Text] [Related]
4. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
[TBL] [Abstract][Full Text] [Related]
5. Uveitis in Behçet's disease.
Nussenblatt RB
Int Rev Immunol; 1997; 14(1):67-79. PubMed ID: 9203027
[TBL] [Abstract][Full Text] [Related]
6. [Ocular manifestations of Behçet's disease].
Saadoun D; Cassoux N; Wechsler B; Boutin D; Terrada C; Lehoang P; Bodaghi B; Cacoub P
Rev Med Interne; 2010 Aug; 31(8):545-50. PubMed ID: 20413190
[TBL] [Abstract][Full Text] [Related]
7. Uveitis in Behçet disease: an analysis of 880 patients.
Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of Behçet's disease in the Indian population.
Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
[TBL] [Abstract][Full Text] [Related]
10. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
Mishima S; Masuda K; Izawa Y; Mochizuki M; Namba K
Trans Am Ophthalmol Soc; 1979; 77():225-79. PubMed ID: 397657
[TBL] [Abstract][Full Text] [Related]
11. [Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review].
Wang Y; Yang L; Zhang ZL
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):910-914. PubMed ID: 27752180
[TBL] [Abstract][Full Text] [Related]
12. Behçet's disease.
Bonfioli AA; Orefice F
Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
[TBL] [Abstract][Full Text] [Related]
13. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Park JY; Chung YR; Lee K; Song JH; Lee ES
Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
[TBL] [Abstract][Full Text] [Related]
14. [Typical and atypical ocular manifestations of Behçet's disease].
Stübiger N; Pleyer U
Ophthalmologe; 2012 Jun; 109(6):558-62. PubMed ID: 22699946
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of ocular involvement in Behçet disease in Tunisia: Monocentric study and review of literature].
Ajili F; Bellakhal S; Ben Abdelhafidh N; Mrabet A; Zouari B; Maalej A; Louzir B; Laabidi J; Othmani S
Pathol Biol (Paris); 2015 Apr; 63(2):85-90. PubMed ID: 25434793
[TBL] [Abstract][Full Text] [Related]
16. Behçet's disease: ocular effects and treatment.
Deuter CM; Kötter I; Wallace GR; Murray PI; Stübiger N; Zierhut M
Prog Retin Eye Res; 2008 Jan; 27(1):111-36. PubMed ID: 18035584
[TBL] [Abstract][Full Text] [Related]
17. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
[TBL] [Abstract][Full Text] [Related]
19. Ocular involvement in Behçet's disease.
Peplinski LS
J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease ocular attack score 24 and visual outcome in patients with Behçet's disease.
Tanaka R; Murata H; Takamoto M; Ohtomo K; Okinaga K; Yoshida A; Kawashima H; Nakahara H; Fujino Y; Kaburaki T
Br J Ophthalmol; 2016 Jul; 100(7):990-994. PubMed ID: 26553921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
